Sai Sheng Pharmaceutical: Ma Li and Liu Shuqin reduced their holdings by 2% within 3 months.

Sai Sheng Pharmaceutical announced that two shareholders, Ma Li and Liu Shuqin, hold 29.8468 million shares and 8.748 million shares, accounting for 6.2% and 1.82% respectively. They plan to reduce their holdings by a total of no more than 9.6333 million shares, or no more than 2%, through centralized bidding and block trades from October 21, 2025 to January 20, 2026. Among them, centralized bidding will not exceed 4.8167 million shares, accounting for 1%; block trades will not exceed 4.8167 million shares, accounting for 1%.